P3M-24794-90522
3 vaccinations
3 coded responses
32 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Registered in v-safe
-
2021-03-01
Dose 1 — Pfizer-BioNTech
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-08
- 2021-03-15
-
2021-03-22
Dose 2 — Pfizer-BioNTech
- 2021-03-22
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-28
- 2021-05-05
-
2021-10-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · NauseaAdult check-in
- 2021-10-08
-
2021-10-10
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Runny/stuffy noseMedDRA releases: 2024-11 · check-in free text available
-
2021-10-13
Survey response — day 7, dose 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-10-20
- 2021-10-25
- 2021-11-01
-
2022-01-03
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-03
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-01 | Pfizer-BioNTech | |
| 2 | 2021-03-22 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Runny/stuffy nose
Release 10 — day 7, dose 3
Systemic reaction (other): Runny nose
Release 10 — 3 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release